Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

在罗宾逊夫人沉醉于希尔伯特第十问题的那些年里，幼年患病所留下的后遗症一再困扰着她。当年的一位医生甚至预言她的心脏机能受损严重，也许活不过40岁。这一预测虽然很幸运地由于后来的一次成功的心脏手术而没有成为事实，但每一年的生日，罗宾逊夫人都要在吹熄蜡烛的 ...

In a re-evaluation of Hockett's foundational features that have long dominated linguistic theory—concepts like "arbitrariness ...

I put Gemini 3.0 and Grok 4.1 through 9 head-to-head prompts — from logic and creativity to humor and tone. Here's what ...

Cognitive scientist Steven Pinker’s new work helps understand markets, revolutions, social media and more ...

If the company is forced to offload even 100,000 of its 649,870 coins to meet obligations, it could trigger a systemic ...

Understand flash loan security risks and exploits. Learn how attackers manipulate oracles and governance, and discover best ...

Ahmedabad (Gujarat) [India], November 25: Infopercept, a global platform-led managed security services company, today released its 2026 Threat Predictions Report, outlining how artificial intelligence ...